Raghuvir Synthetics Intrinsic Value

Raghuvir Synthetics (RAGHUSYN) median intrinsic value is ₹172.74 from 3 valuation models (range ₹85–₹216), vs current price ₹86.37 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. See RAGHUSYN P/B ratio to compare market price against book value per share.

Market Price (CMP)
₹86.37
Primary Intrinsic Value
₹85.00
Market Cap
₹34.5 Cr
+100.0% Upside
Median Value
₹172.74
Value Range
₹85 - ₹216
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

RAGHUSYN Valuation Methods Summary — DCF, Graham Number & P/E

Raghuvir Synthetics intrinsic value across 3 models vs current price ₹86.37 — upside/downside and value range per method. Check RAGHUSYN market cap trends to track the company's total market size over time.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹85.00 ₹76.50 - ₹93.50 -1.6% Book Value/Share: ₹85.00, P/B: 1.0x
Revenue Multiple Method revenue ₹172.74 ₹155.47 - ₹190.01 +100.0% Revenue/Share: ₹240.00, P/S: 0.8x
Simple DCF (5Y) dcf ₹215.93 ₹172.74 - ₹259.12 +150.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

RAGHUSYN Intrinsic Value vs Market Price — All Valuation Models

Raghuvir Synthetics fair value range ₹85–₹216 vs current market price ₹86.37 across 3 valuation models. For current market price and key ratios, visit RAGHUSYN share price screener.

RAGHUSYN Intrinsic Value Analysis — Undervalued or Overvalued?

Raghuvir Synthetics median intrinsic value ₹172.74, current price ₹86.37 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of RAGHUSYN?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Raghuvir Synthetics (RAGHUSYN) is ₹172.74 (median value). With the current market price of ₹86.37, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹85.00 to ₹215.93, indicating ₹85.00 - ₹215.93.

Is RAGHUSYN undervalued or overvalued?

Based on our multi-method analysis, Raghuvir Synthetics (RAGHUSYN) appears to be trading below calculated value by approximately 100.0%.

RAGHUSYN Financial Health — Key Ratios vs Industry Benchmarks

Raghuvir Synthetics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 1.65 Industry Standard: 2.0+ Above 1.5 Measures short-term liquidity capacity
Return on Equity -47.1% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -5.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.81x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

RAGHUSYN Cash Flow Quality — Operating & Free Cash Flow

Raghuvir Synthetics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹24 Cr ₹18 Cr Positive Free Cash Flow 8/10
March 2024 ₹16 Cr ₹11 Cr Positive Free Cash Flow 8/10
March 2023 ₹14 Cr ₹-1 Cr Positive Operating Cash Flow 6/10
March 2022 ₹7 Cr ₹4 Cr Positive Free Cash Flow 8/10
March 2021 ₹5 Cr ₹2 Cr Positive Free Cash Flow 7/10